Streetbeat News

Analyst Ratings

TTEC

Barrington Research analyst Vincent Colicchio has upgraded TTEC Holdings (NASDAQ:TTEC) from Market Perform to Outperform.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:05 pm

NTLA

Goldman Sachs analyst Salveen Richter has maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) but has reduced the price target from $157 to $136.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:05 pm

HCM

Goldman Sachs analyst Paul Choi has maintained a Neutral rating on HUTCHMED (China) (NASDAQ:HCM) but increased the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:04 pm

CWBC

Janney Montgomery Scott analyst Timothy Coffey has upgraded Community West Bancshares (NASDAQ:CWBC) from Neutral to Buy, indicating a positive outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:03 pm

GDRX

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on GoodRx Holdings (NASDAQ:GDRX) but has lowered the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:03 pm

FVRR

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Fiverr Intl (NYSE:FVRR) but has reduced the price target from $49 to $43.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:02 pm

EVBG

Goldman Sachs analyst Kash Rangan has maintained a Sell rating on Everbridge (NASDAQ:EVBG) and reduced the price target from $27 to $23.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:01 pm

UTZ

Utz Brands (NYSE:UTZ) has received a mix of analyst ratings in the last quarter, with 1 bullish, 6 somewhat bullish, and 2 indifferent. The average 12-month price target from 9 analysts is $15.78, which is an 18.37% decrease from the previous target of $19.33. The ratings suggest a cautious optimism among analysts, with no bearish or somewhat bearish ratings reported.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:00 pm

EMR

Emerson Electric (NYSE:EMR) received 9 analyst ratings in the last quarter with an average price target of $109.56, representing an implied upside from the current price of $85.841. The consensus among analysts appears to be more bullish, with 3 bullish and 4 somewhat bullish ratings, and no bearish sentiments. The average price target has increased by 5.14% from the previous target of $104.20.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:00 pm

DUOL

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Duolingo (NASDAQ:DUOL) and increased the price target from $140 to $160.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:00 pm